We are pleased to present our 2020 Year in Review, showcasing the important progress we’ve made in the fight against Alzheimer’s disease over the last year
right here in Massachusetts and New Hampshire. Our staff, community partners, volunteers, and public policy advocates have worked tirelessly to support the 156,000 individuals living with this disease across our two states.
The COVID-19 pandemic has presented unprecedented challenges for our staff and the families we serve, but we are adapting to this “new normal” and continuing to provide care and support for our constituents. All staff are working remotely, and we are delivering our education programs, support groups, and early-stage engagement programs virtually. Our 24/7 Helpline remains fully operational, and our fundraising events continue to happen, albeit in a virtual environment. Despite these challenges, we are proud of all we have accomplished over the course of the year. We reached over 24,000 people through our education programs and community outreach efforts, and continued to provide direct support by conducting over 4,427 care consultations at no cost to families.
This year, our generous supporters helped us raise over $14 million to continue to fund research and care and support programs in local communities across our two states. Our advocacy efforts resulted in increased COVID-19 transparency, reporting and support for health care workers in all nursing homes, assisted living residences and senior housing both here in Massachusetts and New Hampshire and in states across the nation.
We continue to expand our diversity and inclusion efforts, reaching into new communities and strengthening our volunteer base, while expanding our awareness activities into underserved communities to reach high-risk populations. We created a new Diversity & Inclusion Committee as part of the Board of Directors so that we can continue to focus on these efforts.
And finally, we have over $14 million in active funding awarded to local researchers through our International Research Grants Program, ensuring that we will continue to have an impact on the quest for an effective treatment and cure for this devastating disease.
All of this wouldn’t be possible without you, and we are tremendously grateful for your continued support.
Mike Henry, Chair, Board of Directors
James Wessler, CEO, MA/NH Chapter and New England Regional Leader